ATE206428T1 - Spiro-ketal derivate und ihre verwendung als therapeutische wirkstoffe - Google Patents

Spiro-ketal derivate und ihre verwendung als therapeutische wirkstoffe

Info

Publication number
ATE206428T1
ATE206428T1 AT97903437T AT97903437T ATE206428T1 AT E206428 T1 ATE206428 T1 AT E206428T1 AT 97903437 T AT97903437 T AT 97903437T AT 97903437 T AT97903437 T AT 97903437T AT E206428 T1 ATE206428 T1 AT E206428T1
Authority
AT
Austria
Prior art keywords
pct
spiro
active ingredients
therapeutic active
ketal derivatives
Prior art date
Application number
AT97903437T
Other languages
English (en)
Inventor
Jason Matthew Elliott
Fintan Kelleher
Christopher John Swain
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Application granted granted Critical
Publication of ATE206428T1 publication Critical patent/ATE206428T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AT97903437T 1996-02-15 1997-02-12 Spiro-ketal derivate und ihre verwendung als therapeutische wirkstoffe ATE206428T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9603137.2A GB9603137D0 (en) 1996-02-15 1996-02-15 Therapeutic agents
PCT/GB1997/000383 WO1997030055A1 (en) 1996-02-15 1997-02-12 Spiro-ketal derivatives and their use as therapeutic agents

Publications (1)

Publication Number Publication Date
ATE206428T1 true ATE206428T1 (de) 2001-10-15

Family

ID=10788765

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97903437T ATE206428T1 (de) 1996-02-15 1997-02-12 Spiro-ketal derivate und ihre verwendung als therapeutische wirkstoffe

Country Status (9)

Country Link
US (1) US6127365A (de)
EP (1) EP0880528B1 (de)
JP (1) JP2000505442A (de)
AT (1) ATE206428T1 (de)
AU (1) AU716691B2 (de)
DE (1) DE69707104T2 (de)
ES (1) ES2163730T3 (de)
GB (1) GB9603137D0 (de)
WO (1) WO1997030055A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5929094A (en) * 1996-10-25 1999-07-27 Merck & Co., Inc. Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists
GB9625843D0 (en) * 1996-12-12 1997-01-29 Merck & Co Inc Phenyl spiroethercycloalkyl tachykinn receptor antagonists
US6335364B1 (en) * 1998-06-29 2002-01-01 Parker Hughes Institute Synthetic spiroketal pyranes as potent anti-cancer agents
US6858592B2 (en) 2001-06-29 2005-02-22 Genzyme Corporation Aryl boronic acids for treating obesity
US7041280B2 (en) 2001-06-29 2006-05-09 Genzyme Corporation Aryl boronate functionalized polymers for treating obesity
AR041386A1 (es) * 2002-09-24 2005-05-18 Combinatorx Inc Metodos y reactivos para el tratamiento de enfermedades y trastornos asociados con niveles aumentados de citoquinas proinflamatorias
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
DE102007010077B4 (de) * 2007-02-28 2010-04-08 RUHR-UNIVERSITäT BOCHUM [1,3]-Dioxane zur Modulation von GABAa-Rezeptoren
ES2794801T3 (es) 2015-10-23 2020-11-19 Esteve Pharmaceuticals Sa Compuestos oxaazaespíricos con actividad contra el dolor
US11425169B2 (en) 2016-03-11 2022-08-23 Netskope, Inc. Small-footprint endpoint data loss prevention (DLP)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2099233A1 (en) * 1992-06-29 1993-12-30 Conrad P. Dorn Morpholine and thiomorpholine tachykinin receptor antagonists
US5719147A (en) * 1992-06-29 1998-02-17 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
DE69412067T2 (de) * 1993-01-28 1999-03-25 Merck & Co Inc Substituierte spiro-azaringen als tachykinine rezeptor antagonisten
ATE166650T1 (de) * 1993-03-04 1998-06-15 Pfizer Spiroazacyclischderivate als substanz p antagonisten
CA2163995A1 (en) * 1993-06-07 1994-12-22 Malcolm Maccoss Spiro-substituted azacycles as neurokinin antagonists
US5434158A (en) * 1994-04-26 1995-07-18 Merck & Co., Inc. Spiro-substituted azacycles as neurokinin-3 antagonists
GB9426103D0 (en) * 1994-12-23 1995-02-22 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
DE69707104D1 (de) 2001-11-08
EP0880528B1 (de) 2001-10-04
EP0880528A1 (de) 1998-12-02
GB9603137D0 (en) 1996-04-17
DE69707104T2 (de) 2002-06-20
JP2000505442A (ja) 2000-05-09
WO1997030055A1 (en) 1997-08-21
US6127365A (en) 2000-10-03
ES2163730T3 (es) 2002-02-01
AU1799297A (en) 1997-09-02
AU716691B2 (en) 2000-03-02

Similar Documents

Publication Publication Date Title
DE69528823T2 (de) Morpholinwirkstoffvorläufer als tachykininreceptorantagonisten
DE69616480T2 (de) Piperidinderivate als neurokininantagonisten
ES2120170T3 (es) Antagonistas azaciclicos gem-disustituidos de taquiquininas.
ATE247096T1 (de) Tetrahydropyranderivate und deren verwendung als therapeutische mittel
ATE340781T1 (de) Cyclohexylderivate und ihre anwendung als therapeutische mittel
EA199900045A1 (ru) Производные спиропиперидина и их использование в качестве терапевтических агентов
ES2128791T3 (es) Derivados espirocetales, composiciones que los contienen y su uso como agentes terapeuticos.
SE9604786D0 (sv) New compounds
ATE119520T1 (de) Derivate von hydroxaminsäure und von n- hydroxyharnstoff sowie ihre verwendung.
DE69735482D1 (de) Spiro-azacyclische derivate, deren herstellung und verwendung als tachykinin-antagonisten
TR199900856T2 (xx) Bron�la ilgili terapi maddeleri olarak benzonaftiridinler
ATE206428T1 (de) Spiro-ketal derivate und ihre verwendung als therapeutische wirkstoffe
EE200200337A (et) Uued ühendid ning nende kasutamine
BG105710A (en) 5ht1 antagonists for antidepressant therapy
DE69512940D1 (de) N-hydroxy-harnstoff-derivate als entzündunghemmende mittel
ATE187956T1 (de) Substituierte kondensierte und verbrückte bicyclische verbindungen als therapeutische mittel
TR199901395T2 (xx) Yeni karboksi ikameli siklik karboksamid t�revleri.
PL343848A1 (en) Novel benzimidazoles and benzoxazoles
SE9802207D0 (sv) Novel compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties